Halozyme temporarily halts pancreatic cancer study
(Reuters) - Halozyme Therapeutics Inc said it was temporarily halting enrolment of patients and dosing of its cancer drug in a mid-stage trial on pati...
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/XiFEiirjpDM/story01.htm
No comments:
Post a Comment